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Abstract
We demonstrate the application of non-gated laser induced breakdown spectroscopy (LIBS) for characterization and
classification of organic materials with similar chemical composition. While use of such a system introduces substantive
continuum background in the spectral dataset, we show that appropriate treatment of the continuum and characteristic
emission results in accurate discrimination of pharmaceutical formulations of similar stoichiometry. Specifically, our results
suggest that near-perfect classification can be obtained by employing suitable multivariate analysis on the acquired spectra,
without prior removal of the continuum background. Indeed, we conjecture that pre-processing in the form of background
removal may introduce spurious features in the signal. Our findings in this report significantly advance the prior results in
time-integrated LIBS application and suggest the possibility of a portable, non-gated LIBS system as a process analytical
tool, given its simple instrumentation needs, real-time capability and lack of sample preparation requirements.
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Introduction
One of the major objectives of Process Analytical Technologies,
conceptualized by the U.S. Food and Drug Administration in the
last decade, is the development of novel sensor devices that can be
incorporated in the manufacturing process loop to enable in-
process material characterization [1]. Such a method can assist in
better monitoring each step of the formulation development and
manufacturing process and, therefore, in real-time control of the
process itself. However, there is a lack of analytical tools that can
perform rapid on-line determination of the consistency of the drug
constituents (especially the active pharmaceutical ingredient, API)
in order to ensure the potency, purity and bioavailability of the
final product. Laser-induced breakdown spectroscopy (LIBS) is an
emerging instrument in the analytical toolkit, as it can provide
real-time analysis with minimal or no sample preparation [2–5]. In
LIBS, the emission from the plasma plume, induced by laser
photons, forms the basis for extraction of analytical information
about the material under investigation [6]. The deionization
radiation is primarily characteristic of the elemental composition,
although emission from molecular fragments may also be observed
[7]. Because of its real-time diagnostic capability, LIBS can be
potentially used for testing a larger number of samples in
comparison to existing analytical tools (e.g. high performance
liquid chromatography (HPLC)), with the additional possibility of
high-resolution surface mapping and depth profiling. However,
despite these intrinsic advantages, LIBS systems have hitherto not
been employed for online process monitoring [4,6]. The primary
bottlenecks towards more extensive usage, particularly for
screening applications, is the lack of robustness and resource-
intensive, unwieldy nature of the conventional LIBS spectrometers
that use gated intensified detectors (primarily intensified charge-
transfer devices (ICCD)) for spectral recording. This is further
compounded by the large spatial footprint and weight of these
systems as well as the considerable maintenance and technical
expertise required for its routine use.
Application of gated detection is based on the prevailing view
that discrimination against the early ‘‘uncharacteristic’’ continuum
signal (from radiative recombination and Bremsstrahlung emis-
sion) is critical for quantitative analysis [8]. As a consequence,
most of the reports have focused on a suitable time window of
acquisition where the condition of local thermodynamic equilib-
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rium (LTE) is satisfied [9]. While this perspective is largely justified
for trace element analysis as well as suppression of matrix effects in
certain specimen [10], such gating may not be necessary for
classification applications even when dealing with samples of
similar chemical composition. We have suspected that it is possible
to obtain similar levels of performance without gated detection by
appropriately utilizing the features across the entire spectral
window of collection. In fact, the distinctiveness of the plasma
produced by different samples may result in subtle differences in
the broad continuum signals, which in turn could positively aid
performance of the classification models. Classical ratiometric
analysis based on a study of a few channel (wavelength) traces has
limited capability of dealing with segmenting such spectral datasets
due to the overlap of the continuum and characteristic emission
signals and to the impossibility of detecting interfering species in
the measured signal. Our prior experience with analysis of Raman
spectra acquired from biological samples in the presence of
substantive luminescence backgrounds [11] further strengthens
our belief that multivariate classification of non-gated LIBS spectra
can be successfully implemented despite the presence of the
continuum background signals. Here, we seek to investigate the
capability of non-gated LIBS for differentiation of pharmaceutical
samples of similar elemental composition by concomitant treat-
ment of continuum and characteristic emission. This work extends
the recent efforts in understanding the role of continuum radiation
in LIBS [12] and its application in metal alloy identification [13]
to analysis of organics (e.g. API) of similar composition.
In this article, we report the application of LIBS measurements
to classify pharmaceutical formulations in solid dosage forms,
without employing gated detectors or echelle spectrographs. Our
non-gated LIBS measurements reveal that despite the presence of
substantive continuum emission, the acquired signals exhibit
subtle, but consistent, changes in spectral features. By correlating
the spectra with the corresponding class of samples, we have
developed predictive models based on soft independent modeling
of class analogy (SIMCA), artificial neural networks (ANN) and
partial least squares discriminant analysis (PLSDA). Our multi-
variate analysis shows very high diagnostic power with correct
classification accuracy levels in excess of 90% with SIMCA and
100% with ANN and PLSDA, even when measurements are
performed under ambient air conditions. Taken together with our
recent development of a sensitive and robust support vector
machine platform [14], these results provide a powerful toolkit in
the minimally perturbative process monitoring (on-line and at-line)
and quality control domains in the pharmaceutical industry. While
this report provides a proof of concept demonstration of the latent
diagnostic power of a simple portable LIBS system, we are
currently in the process of validating our results on a larger matrix
of samples including specimen spiked with trace foreign elements
to mimic the scenario of counterfeit drugs. Ultimately, we envision
that the substantive advantages of using non-gated detection in
LIBS in terms of cost, maintenance and simpler instrumentation
will enable its ready translation to compact devices tailored for the
pharmaceutical and food industries as well as for forensic and
biological specimen analysis.
Materials and Methods
The details of the experimental methods, instrumentation and
data analysis steps are provided in File S1. Briefly, a set of
pharmaceutical samples (namely Cetirizine dihydrochloride,
Metformin hydrochloride, Cipro pure and Ciprofloxacin hydro-
chloride) was acquired from the local drug manufacturer in
powder form. To simulate the in-line testing of tablets, the fine
powder material was pressed into ca. 1 cm diameter pellets by a
die-hydraulic press combination. The LIBS system used a
frequency-doubled Nd:YAG laser (lex = 532 nm, 7 ns pulse width,
Spit light 1200, InnoLas LaserGmbH, Germany) for excitation
and the emission signal was recorded using a non-gated
spectrometer (Ocean Optics, MAYA 2000). Notably, the detector
unit comprised of a conventional Czerny-Turner spectrograph for
dispersion instead of the higher resolution echelle spectrograph
allowing us to assess a lower bound for the classification
performance. The samples were subjected to ca. 6 mJ of laser
energy. All of the LIBS spectra were collected under ambient
conditions. The data can be found in Data S1. A motorized XY
stage was employed to enable a fresh portion of the sample to be
interrogated after acquiring multiple spectra from a single
location.
Subsequent to acquisition and pre-processing of the spectral
data, principal component analysis (PCA) was employed as a data
exploration and dimensionality reduction step. For quantifying the
classification ability of the LIBS dataset, we selected SIMCA, PLS-
DA and ANN as representative methods. Chemometric calcula-
tions, including dendrogram analysis-based outlier detection and
subsequent classification, were conducted using MatlabR2010b
(Math Works, Natick, MA). Following removal of outliers, a total
of 403 LIBS spectra were used in the classification analysis, with
more than 90 spectra from each of the four pharmaceutical
formulations.
Results
Figure 1 shows representative spectra acquired from the
Cetirizine dihydrochloride, Cipro pure, Metformin hydrochloride,
and Ciprofloxacin hydrochloride pellets. The discontinuity in the
wavelength axis is due to the omission of a 30 nm wide band
surrounding the 532 nm laser line, which otherwise causes
significant interference in the non-gated signal. The corresponding
intensity values are disregarded from the ensuing analysis. From
Fig. 1, it is notable how similar the LIBS spectra from each of the
pharmaceutical samples are, due to the relatively similar
formulation of the API. Further, any differences that may exist
(for example, the absence of oxygen in metformin hydrochloride)
are obviated by the presence of the corresponding element(s) in air.
A complete listing of the prominent peaks in Fig. 1 is provided in
Table S1. Evidently, the early continuum emission (present as
broad featureless background) constitutes a substantive component
of the acquired spectra. Despite the apparent featureless nature,
however, it is possible that the subtle differences in the continuum
emission signals may provide discriminatory power – particularly
when viewed in light of the similarity of the characteristic emission
lines in Fig. 1.
To systematically investigate the presence of subtle differences
between the LIBS spectra of each type of pharmaceutical sample,
principal component analysis (PCA) was used. The principal
components are linear combinations of the acquired signals and
capture the spectral variance in a reduced dimensional space.
Figure 2 shows the first three principal components, which
together account for 96.5% of the net variance in the spectral
dataset. In particular, the first two PCs explain 93% of the
variance present in the dataset, with the first one contributing
84.3%. Expectedly, the subsequent PCs after the first three are
mostly dominated by noise. We observe that PC1 shows only a
single dominant hydrogen emission line at ca. 657 nm on a broad
background that can be ascribed to the early continuum emission.
PC2 and PC3 exhibit mostly characteristic emission lines including
those at ca. 479.45 nm (chlorine), 500 nm (nitrogen), 567 nm
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(nitrogen), 747 nm (nitrogen), 777 nm (oxygen) and 868 nm
(oxygen). The primary differences between PC2 and PC3 are in
the relative intensities of these lines and also in the presence of a
small background for PC2, especially in the lower wavelength
region.
The corresponding scores plot for PC 1, PC 2 and PC 3 is
provided in Fig. 3(A). From the figure, it is evident that the
Figure 1. Representative LIBS spectra acquired from the pharmaceutical formulation investigated in this report. (a) Cetirizine
dihydrochloride; (b) Cipro pure; (c) Metformin hydrochloride; (d) Ciprofloxacin hydrochloride. Intensity on the y-axis is normalized with respect to the
characteristic hydrogen emission peak at 656 nm.
doi:10.1371/journal.pone.0103546.g001
Figure 2. Plot of the first three principal components corresponding to the entire spectral dataset acquired for all classes. These
three principal components, combined, explain 96.5% of the net variance in the dataset.
doi:10.1371/journal.pone.0103546.g002
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samples of each class tend to form a cluster and in general appear
to show good separation from the other classes. In particular,
Cetirizine dihydrochloride, Cipro pure and Ciprofloxacin hydro-
chloride are clearly distinguishable based on the PC scores
obtained from the acquired LIBS spectra. However, the scatter in
the PC scores for the Metformin hydrochloride spectra makes its
separation more challenging, particularly from the Cetirizine
dihydrochloride cluster. The scatter in the PC scores arises
primarily from the inhomogenity of the fabricated pellets as well as
the potential non-sample specific variance introduced by non-
gated detection. Additionally, the overlap in the the Metformin
hydrochloride and the Cetirizine dihydrochloride clusters can also
be attributed to the absence of any distinguishing element between
the two formulations, i.e. both formulations in ambient air
conditions exhibit emission lines of carbon, hydrogen, oxygen,
nitrogen and chlorine. This is in contrast to the Cipro pure and
Ciprofloxacin hydrochloride samples that contain fluorine in their
corresponding API. Nevertheless, in totality, this exploratory data
analysis of the non-gated LIBS data reveals that the chemical basis
in the form of PCs gives rise to a substantive degree of separation
of the data points corresponding to a particular pharamceutical
formulation – which is promising for the development of models
for classifying and screening these and similar pharmaceutical
tablets.
To ensure suitable quality of the data for the development of
classification algorithms, hierarchical clustering by means of
dendrogram analysis was first pursued. In this case, we exploit
the grouping of the objects in a dendrogram to detect outliers
Figure 3. Discrimination of pharmaceutical samples based on their LIBS spectra. (A) Scores plot corresponding to principal components 1,
2 and 3 for the spectral dataset acquired from the four samples. The data points corresponding to Cetirizine dihydrochloride, Cipro pure, Metformin
hydrochloride and Ciprofloxacin hydrochloride are indicated by green squares, blue circles, black asterisks and yellow inverted triangles, respectively.
(B) Hierarchical clustering using the dendrogram representation for LIBS spectra acquired from the 4 sets of pharmaceutical samples.
doi:10.1371/journal.pone.0103546.g003
Table 1. SIMCA classification results obtained from the test samples over 100 iterations.
Average rate of… Correct classification Misclassification Unclassification
Cetirizine dihydrochloride 1.00 0.00 0.00
Cipro pure 0.86 0.00 0.14
Metformin hydrochloride 0.82 0.00 0.18
Ciprofloxacin hydrochloride 0.96 0.00 0.04
Average 0.91 0.00 0.09
doi:10.1371/journal.pone.0103546.t001
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based on the presence of isolated branches. Moreover, dendro-
gram analysis was also used to obtain class similarity between the
different pharmaceutical formulations. In this case, the mean
spectrum for each formulation was computed from all the spectra
acquired from that formulation barring the detected outlier
spectra. Figure 3(B) shows the resultant dendrogram obtained by
analyzing the mean spectrum of the four formulations. This
corroborates the PCA findings as one clearly observe that the
Metformin hydrochloride exhibits spectral similarity to Cetirizine
dihydrochloride in comparison to the other formulations.
In order to evaluate the suitability of the non-gated LIBS data
for classification purposes, SIMCA was chosen to develop the
discrimination algorithm. Specific to the SIMCA model develop-
ment, 70% of the samples were designated as training data while
the rest of the samples (30%) were held out of the model building
and served as the test set. It was ensured that the spectra
corresponding to each pharmaceutical formulation were split as
per these representative percentage values. In order to obtain a
representative estimate of the rates of correct classification,
misclassification and unclassification, 100 independent iterations
were performed by re-splitting the entire data into training and test
sets. Here, the model is judged to be sensitive if the correct
classification rate is high and the unclassification rate is low.
Table 1 gives the results of the classification analysis for the
SIMCA-derived discrimination model for the four pharmaceutical
formulations, based on the 3s unclassification threshold (Sup-
porting information). The misclassification rate is observed to be
0%, irrespective of the pharamceutical formulation in question.
The correct classification accuracy varies from 82% (Metformin
hydrochloride) to 100% (Cetirizine dihydrochloride). Based on the
PCA and dendrogram analysis, the relatively lower classification
accuracy (and correspondingly, the higher unclassification rate) of
the Metformin hydrochloride sample is not surprising. The
inherent scatter of the sample data seems to be the predominant
factor in the relatively inferior performance of the SIMCA model
for Metformin hydrochloride and Cipro pure classification with
unclassification rates observed to be 18% (Metformin hydrochlo-
ride) and 14% (Cipro pure), respectively. On average, the SIMCA-
derived model provides a correct classification rate of 91%, which
suggests that the non-gated LIBS spectral measurements, even
under ambient air conditions, provides sufficient information for
sensitive discrimination of the studied formulations. It is worth
mentioning that these results are comparable to our previous
results obtained from gated LIBS spectra of similar pharmaceu-
tical samples [14,15] - indicating that the presence of the
continuum emission signals does not hinder the statistical
performance, especially on application of suitable multivariate
algorithms. To the best of our knowledge, this provides the first
experimental demonstration of the suitability of non-gated data for
classification of complex samples with the principal constituents
(i.e. the APIs) having similar composition.
Finally, to more comprehensively examine the classification
capability of the acquired non-gated data, PLS-DA and ANN
models were also constructed. For PLS-DA, a single ‘‘global’’
model is obtained for classification, in contrast to the independent
PCA submodels developed for SIMCA analysis. Using this single
global PLS-DA model, we were able to obtain 100% correct
classification accuracy for all formulations (Table 2). While the
underlying principle of PLS-DA to obtain maximum separation
between classes (as opposed to modeling the maximum variance in
each individual class in SIMCA) may be partially responsible for
the improvement, the presence of dataset-specific factors cannot
be neglected. For example, we had previously observed for the
corresponding gated data that SIMCA was marginally more
sensitive, even though PLS-DA was significantly more robust in
classifying unknown samples [14]. Furthermore, application of
ANN also yields no misclassification or unclassification (Table 3).
Given the nonlinear nature of the ANN algorithm and the
potential interferent sources in the non-gated data, the enhanced
performance in this case, with respect to SIMCA, is not wholly
unexpected (e.g. application of support vector machine (SVM)
derived segmentation model greatly improved the sensitvity and
robustness metrics in our gated data [14]. Variability in the
continuum emission, plasma self-absorption and matrix effects
Table 2. ANN classification results obtained from the test samples over 100 iterations.
Average rate of… Correct classification Misclassification Unclassification
Cetirizine dihydrochloride 1.00 0.00 0.00
Cipro pure 1.00 0.00 0.00
Metformin hydrochloride 1.00 0.00 0.00
Ciprofloxacin hydrochloride 1.00 0.00 0.00
Average 1.00 0.00 0.00
doi:10.1371/journal.pone.0103546.t002
Table 3. PLSDA classification results obtained from the test samples over 100 iterations.
Average rate of… Correct classification Misclassification Unclassification
Cetirizine dihydrochloride 1.00 0.00 0.00
Cipro pure 1.00 0.00 0.00
Metformin hydrochloride 1.00 0.00 0.00
Ciprofloxacin hydrochloride 1.00 0.00 0.00
Average 1.00 0.00 0.00
doi:10.1371/journal.pone.0103546.t003
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could contribute towards such nonlinear changes in intensity ratios
in the features of interest.
Discussion
In addition to quantifying the classifier performance based on
non-gated LIBS spectra, it is imperative to precisely understand
the impact of the continuum emission background. As alluded to
above, the prevailing thought in the LIBS community has centered
around the uncharacteristic nature of the continuum emission, as
it emanates from radiative recombination and Bremsstrahlung
emission that do not depend on the identity of the element/ion
[16]. Considerable contemporary attention has been focused on
the choice of a proper delay time when the ratio of line emission to
background (continuum) emission is very high, since ‘‘only the
lines emission from the plume is important for the compositional
analysis of the sample target’’ [6].
To test this hypothesis, we have compared the aforementioned
results using non-gated LIBS spectra to those where the
continuum background is removed using a lower order polyno-
mial. Since the continuum background is broad and featureless,
previous investigators have employed several numerical post-
processing schemes to approximate and remove it from the
acquired spectral data [17,18]. Here, the background of the LIBS
spectra was removed by application of an iterative least squares-
based curve-fitting algorithm that uses a polynomial (6th order for
our dataset) with non-negativity constraints [19]. This algorithm
(and its variants) have been extensively used for addressing broad
backgrounds in similar spectroscopic data featuring small charac-
teristic peaks and large backgrounds [20,21]. Representative
background-removed LIBS spectra from each pharmaceutical
formulation are shown in Fig. S1. Subsequent to background
removal, all the spectra were subjected to the same protocol as
described above, namely dendrogram analysis for outlier removal
and SIMCA for development of the discrimination algorithm.
Using 100 iterations on the partitioned test sets (30%), we observe
that, in this case, the SIMCA-derived models provide an average
correct classification rate of 88% with a corresponding misclassi-
fication and unclassification rates of 0% and 12%, respectively.
Based on the average correct classification rates and the
corresponding standard deviations for the non-gated LIBS data
with and without background removal, the two-tailed p-value is
computed to be less than 0.0001. By conventional criteria (i.e.
rejection of null hypothesis at p-value less than 0.01), this
difference can be considered to be extremely statistically signifi-
cant. It is also observed that the reduction in correct classification
rate relative to Table 1 is consistent for all the pharmaceutical
formulations. The difference in correct classification rate on
application of SIMCA on the two datasets could be attributed to:
(A) the presence of diagnostic information in the continuum
background; and/or (B) introduction of artifacts due to the
background removal procedure that results in deterioration of
model performance. Further experiments with a range of time
delays (currently underway in our laboratories) are necessary to
elucidate whether the continuum background may indeed aid
specific classification analyses.
Finally, it is worth analyzing the influence of the additional
noise component incorporated in the non-gated LIBS data due to
the continuum emission background. Overall, the relative root-
mean-square noise in a spectrum has two contributions, namely
the constant fixed-pattern noise characterizing the non-uniform
response of the CCD pixels and the shot noise. Given the high
signal levels of LIBS data, the latter has lesser significance and can
always be reduced relative to the signal level by acquiring for
longer time periods. The better signal-to-noise characteristics of
the CCD detectors employed for non-gated detection in relation to
the ICCD used for gated detection also alleviates this problem.
Additionally, employing a suitable flat-field correction scheme can
eliminate the more relevant fixed-pattern noise for high intensity
LIBS data. Recently, researchers have detailed a promising fixed-
pattern noise removal approach that focuses on subtraction of
spectra acquired before and after shifting of spectrometer grating
[22], which can be suitably employed in future non-gated LIBS
studies to enhance classifier performance.
Concluding Remarks
In summary, we have proposed and demonstrated the potential
of non-gated LIBS for identification and classification of pharma-
ceutical formulations with similar elemental compositions. It is
observed that the non-gated spectra shows high efficacy in
discrimination with an average correct classification rate of 91%.
Importantly, from a scientific standpoint, we observe that the
presence of the continuum background in the non-gated LIBS
dataset does not impede the classification performance. We
envision that the significant advantages of this detection method
in terms of cost, maintenance and system portability, coupled with
its sensitivity, will ideally complement the existing analytical
technologies for determination of surface and internal distribution
of API and excipients [23], in addition to verification of the drug
content in the finished dosage form. This will enable its ready
translation to compact devices tailored for various industrial
applications like food, pharmaceutical, biological and forensic.
The sensitivity of this LIBS approach can be further enhanced by
implementing hybrid classification schemes, which feature a range
of (linear and non-linear) chemometric strategies [24]. With
further refinements in the classification methodologies as well as
development of a hand-held LIBS monitor, the approach
presented here can be extended for sensitive identification in
other critical applications including detection of high energy and
hazardous materials [25].
Supporting Information
Figure S1 Background corrected LIBS spectra acquired
from the pharmaceutical formulation investigated in
this report. (a) Cetirizine dihydrochloride; (b) Cipro pure; (c)
Metformin hydrochloride; (d) Ciprofloxacin hydrochloride. Inten-
sity on the y-axis is normalized with respect to the characteristic
hydrogen emission peak at 656 nm. The continuum background is
approximated and removed using a least squares-based polyno-
mial curve-fitting algorithm.
(TIF)
Table S1 Elemental assignments of the major emission
lines observed in the LIBS spectra acquired from the
pharmaceutical samples used in this study.
(DOC)
Data S1 Supplementary data.
(XLS)
File S1 Supplementary Materials and Methods.
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